Dexamethasone Intravitreal Implant for Early Treatment and Retreatment of Macular Edema Related to Branch Retinal Vein Occlusion: The Multicenter COBALT Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Dexamethasone Intravitreal Implant for Early Treatment and Retreatment of Macular Edema Related to Branch Retinal Vein Occlusion: The Multicenter COBALT Study ; volume:240 ; number:2 ; year:2018 ; pages:81-89
Ophthalmologica ; 240, Heft 2 (2018), 81-89
- Creator
-
Yoon, Young Hee
Kim, Jong Woo
Lee, Joo Yong
Kim, In Taek
Kang, Se Woong
Yu, Hyeong Gon
Koh, Hyoung Jun
Kim, Sung Soo
Chang, Dong-Jin
Simonyi, Susan
- DOI
-
10.1159/000487547
- URN
-
urn:nbn:de:101:1-2018080200044580166830
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:30 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yoon, Young Hee
- Kim, Jong Woo
- Lee, Joo Yong
- Kim, In Taek
- Kang, Se Woong
- Yu, Hyeong Gon
- Koh, Hyoung Jun
- Kim, Sung Soo
- Chang, Dong-Jin
- Simonyi, Susan
Other Objects (12)
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
Risk factors for repeated dexamethasone intravitreal implant therapy for macular edema due to treatment-naïve branch retinal vein occlusion
Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema
Switch of intravitreal therapy for macular edema secondary to retinal vein occlusion from Anti-VEGF to dexamethasone implant and vice versa
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis
Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis
Differential response to intravitreal dexamethasone implant in naïve and previously treated diabetic macular edema eyes
Effect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients : Corneal endothelium after dexamethasone implant injection
Real-life medium term follow-up data for intravitreal dexamethasone implant in retinal vein occlusion
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
Risk factors for repeated dexamethasone intravitreal implant therapy for macular edema due to treatment-naïve branch retinal vein occlusion
Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema
Switch of intravitreal therapy for macular edema secondary to retinal vein occlusion from Anti-VEGF to dexamethasone implant and vice versa
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis
Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis
Differential response to intravitreal dexamethasone implant in naïve and previously treated diabetic macular edema eyes
Effect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients : Corneal endothelium after dexamethasone implant injection
Real-life medium term follow-up data for intravitreal dexamethasone implant in retinal vein occlusion
Intravitreal dexamethasone implant for central retinal vein occlusion without macular edema
Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
Risk factors for repeated dexamethasone intravitreal implant therapy for macular edema due to treatment-naïve branch retinal vein occlusion
Short-term effect of intravitreal dexamethasone implant in refractory diabetic macular edema
Title: efficacy of intravitreal dexamethasone implant on hard exudate in diabetic macular edema
Switch of intravitreal therapy for macular edema secondary to retinal vein occlusion from Anti-VEGF to dexamethasone implant and vice versa
Comparison of the efficacy of intravitreal Anti-VEGF versus intravitreal dexamethasone implant in treatment resistant diabetic Macular Edema
Intravitreal dexamethasone implants versus intravitreal anti-VEGF treatment in treating patients with retinal vein occlusion: a meta-analysis
Intravitreal Triamcinolone Acetonide for Diabetic Macular Edema and Macular Edema Secondary to Retinal Vein Occlusion: A Meta-Analysis
Differential response to intravitreal dexamethasone implant in naïve and previously treated diabetic macular edema eyes
Effect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients : Corneal endothelium after dexamethasone implant injection